Intuitive Surgical, Inc. $ISRG Stake Trimmed by Rathbones Group PLC

Rathbones Group PLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.9% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 421,817 shares of the medical equipment provider’s stock after selling 3,985 shares during the period. Rathbones Group PLC’s holdings in Intuitive Surgical were worth $171,523,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in ISRG. Bank of America Corp DE increased its stake in shares of Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after buying an additional 116,292 shares during the period. Bank of New York Mellon Corp bought a new position in shares of Intuitive Surgical during the second quarter valued at approximately $1,335,753,000. Amundi lifted its stake in Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after acquiring an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after acquiring an additional 1,027,475 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. lifted its stake in Intuitive Surgical by 10.8% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock worth $769,948,000 after acquiring an additional 184,044 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $458.15, for a total transaction of $183,260.00. Following the completion of the transaction, the executive vice president owned 6,236 shares of the company’s stock, valued at approximately $2,857,023.40. This trade represents a 6.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the business’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the sale, the vice president owned 1,026 shares in the company, valued at approximately $464,993.46. This trade represents a 79.78% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 39,363 shares of company stock valued at $17,738,749. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Down 2.0%

ISRG opened at $399.06 on Friday. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The stock has a market cap of $138.33 billion, a PE ratio of 48.25, a PEG ratio of 3.02 and a beta of 1.45. The business has a 50 day moving average of $423.51 and a 200-day moving average of $427.91.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same period in the prior year, the firm earned $2.40 earnings per share. Equities analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Key Headlines Impacting Intuitive Surgical

These are some of the ISRG headlines that stood out recently:

  • Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
  • Neutral Sentiment: An executive sold 46 shares under a pre-arranged Rule 10b5-1 plan. The transaction was small and scheduled in advance, so it is a limited signal about management’s outlook. Insider-sale report
  • Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article

Analysts Set New Price Targets

Several analysts recently weighed in on ISRG shares. Raymond James Financial reiterated an “outperform” rating and issued a $480.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 21st. Oppenheimer restated an “outperform” rating and issued a $500.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 21st. BTIG Research upped their price objective on shares of Intuitive Surgical from $454.00 to $513.00 and gave the stock a “buy” rating in a report on Wednesday. TD Cowen reaffirmed a “buy” rating and issued a $485.00 target price on shares of Intuitive Surgical in a research report on Monday, October 19th. Finally, HSBC cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 target price for the company. in a research report on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $495.90.

Get Our Latest Report on ISRG

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Recommended Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.